Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03619109 · ClinicalTrials.gov registry record
Determination of Normal Reference Values of CRP, Procalcitonin, and Lactate Levels for the Nanōmix eLab® System
A clinical trial, sponsored by Nanomix.
- Completed
- Registry status
- 160
- Enrollment target
NCT03619109 is a clinical trial that has completed, run by Nanomix. The registered enrollment target is 160 participants.
The verdict
NCT03619109 has completed, sponsored by Nanomix.
- COMPLETED
- Registry status
- 160 participants
- Enrollment target
Study Summary
The main objective of this clinical study is to determine the normal reference range of the Nanōmix eLab® (eLab) C-Reactive Protein, Procalcitonin and Lactate Assay.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2017-12-22 |
| Est. Completion | 2019-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03619109
The ClinicalTrials.gov registry entry for NCT03619109 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nanomix, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03619109 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03619109 about?
NCT03619109 is a clinical study titled "Determination of Normal Reference Values of CRP, Procalcitonin, and Lactate Levels for the Nanōmix eLab® System". The main objective of this clinical study is to determine the normal reference range of the Nanōmix eLab® (eLab) C-Reactive Protein, Procalcitonin and Lactate Assay.
What is the current status of trial NCT03619109?
This trial is currently completed. The enrollment target is 160 participants. The study started on 2017-12-22. Estimated completion is 2019-02-28.
Who is sponsoring clinical trial NCT03619109?
This trial is sponsored by Nanomix, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.